#news #biotech AstraZeneca and Sanofi’s antibody prevents RSV in phase 3, accelerating path to market

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca and Sanofi’s antibody prevents RSV in phase 3, accelerating path to market .AstraZeneca and Sanofi’s antibody prevents RSV in phase 3, accelerating path to market
ntaylor
Mon, 04/26/2021 – 04:58

from FierceBiotech: Biotech https://ift.tt/3xn9ydj